Access to investigational drugs for treatment purposes
Nightingale, S.L.; Kimbrough, C.A.; Rheinstein, P.H.
American Family Physician 50(4): 845-847
1994
ISSN/ISBN: 0002-838X PMID: 8079913 Document Number: 430566
Document emailed within 1 workday
Related Documents
Klecker, R.J.; Cipolle, R.J. 1987: Procedures for emergency or treatment use of investigational drugs American Journal of Hospital Pharmacy 44(5): 1086-1089Terlikbayeva, A.; Zhussupov, B.; Primbetova, S.; Gilbert, L.; Atabekov, N.; Giyasova, G.; Ruziev, M.; Soliev, A.; Saliev, D.; El-Bassel, N. 2013: Access to HIV counseling and testing among people who inject drugs in Central Asia: strategies for improving access and linkages to treatment and care Drug and Alcohol Dependence 132(Suppl 1): S61-S64
Moffitt, C.M. 1998: Field trials of investigational new animal drugs Veterinary and Human Toxicology 40(Suppl): 48-52
Kondo, K. 2000: Investigational new drugs among glycoprotein IIb/IIIa-receptor antagonists Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 116(5): 263-268
1986: The role of programmed electrical stimulation in evaluation of investigational antiarrhythmic drugs Circulation 73(2 Pt 2): Ii1-113
Jeppsson, A. 2010: Taxation of basic drugs--a sick tax that prevents access to treatment Lakartidningen 107(11): 776
Nguyen, N.Thi.Thu.; Rasch, V.; Bygbjerg, I.Christian.; Mogensen, H.Overgaard. 2013: Vietnamese women's struggle to access antiretroviral drugs in a context of free treatment Health Care for Women International 34(3-4): 209-226
2008: Nearly three million HIV-positive people now receiving life-saving drugs. But access to prevention and treatment still lacking for millions Central European Journal of Public Health 16(3): 127 133
Grebely, J.; Hajarizadeh, B.; Lazarus, J.V.; Bruneau, J.; Treloar, C. 2019: Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all International Journal on Drug Policy 72: 1-10
Zola, E.M.; Overbach, A.M.; Gunkel, J.H.; Mitchell, B.R.; Nagle, B.T.; DeMarco, N.G.; Henwood, G.A.; Gold, A.J. 1993: Treatment Investigational new Drug experience with Survanta (beractant) Pediatrics 91(3): 546-551
MacArthur, R.B. 1990: Ganciclovir: approved and investigational uses for the treatment of cytomegalovirus retinitis Mount Sinai Journal of Medicine new York 57(6): 378-380
Hetzel, M.W.; Iteba, N.; Makemba, A.; Mshana, C.; Lengeler, C.; Obrist, B.; Schulze, A.; Nathan, R.; Dillip, A.; Alba, S.; Mayumana, I.; Khatib, R.A.; Njau, J.D.; Mshinda, H. 2007: Understanding and improving access to prompt and effective malaria treatment and care in rural Tanzania: the ACCESS Programme Malaria Journal 6: 83
Azétsop, J.; Diop, B.A. 2013: Access to antiretroviral treatment, issues of well-being and public health governance in Chad: what justifies the limited success of the universal access policy? Philosophy Ethics and Humanities in Medicine: Pehm 8: 8
Azétsop, J.; Diop, B.A. 2013: Access to antiretroviral treatment, issues of well-being and public health governance in Chad: what justifies the limited success of the universal access policy? Philosophy Ethics and Humanities in Medicine: Pehm 8: 8
Stern, R.; Beresford, B.; Kimani, D. 2002: Access to essential drugs Developing World Bioethics 2(2): 99-103
Stern, R.; Beresford, B.; Kimani, D. 2002: Access to essential drugs Developing World Bioethics 2(2): 99-103
Gulland, A. 2013: Access to HIV drugs should be widened, says WHO BMJ 347: f4172
Stern, R.; Beresford, B.; Kimani, D. 2002: Access to essential drugs Developing World Bioethics 2(2): 99-103
Fricker, J. 2007: Inequalities in access to renal cancer drugs European Journal of Cancer 43(8): 1226
Mileshkin, L.; Sullivan, D. 2011: Access to expensive anti-cancer drugs Journal of Law and Medicine 19(2): 232-243